CPhi Preview 2013: Jost Chemicals - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

CPhi Preview 2013: Jost Chemicals


Untitled Document

2013 CPhI Exhibitor Preview

Company: Jost Chemical Co.

Description: For almost 30 years, Jost Chemical Co. has manufactured high purity inorganic chemicals for use in API synthesis, as pH buffers, as process intermediates, and in cell culture media and protein synthesis. Jost’s FDA registered site operates under bulk pharmaceutical cGMP. Jost is a global supplier of high purity salts that meet USP/EP/BP/JP monographs, are BSE/TSE free, and Kosher and Halal certified. Our wide selection of 250 + products includes carbonates, nitrates, phosphates and sulfates. Jost also offers DMF and ASMF developments.

Website: www.jostchemical.com

Booth Number: Hall 5.1 Stand D40

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here